Tripartite meeting drew far closer accord on disputed issues.

Published: 2000-11-14 17:19:00

Updated: 2000-11-14 17:19:00

In the 5th tripartite meeting started from 6 p.m. on Nov. 9 to the next day morning at the conference hall of the MOHW, many disputed issues including the substitutive dispensing made closer agreement especially at the working level of the subcommittee. However, the issue on the OTC drug sale at ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK